Efficacy of venetoclax based salvage chemotherapy followed by “Minimal Residual Disease driven”-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia / E. Todisco, F. Gigli, S. Sammassimo, C. Camisaschi, P. Mancuso, C. Ronchini, S. Ramadan, F. Bertolini, R. Pastano, C. Tarella. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 61:9(2020), pp. 2277-2279. [10.1080/10428194.2020.1759049]
Efficacy of venetoclax based salvage chemotherapy followed by “Minimal Residual Disease driven”-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia
C. Camisaschi;C. Ronchini;C. Tarella
2020
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Leukemia & Lymphoma 2020 - Venetoclax in AML.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
967.8 kB
Formato
Adobe PDF
|
967.8 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
